Henoch-Schönlein purpura and thrombocytopenia after planned antiretroviral treatment interruption in a Thai girl with HIV infection

Int J Infect Dis. 2009 Jan;13(1):e31-3. doi: 10.1016/j.ijid.2008.05.1225. Epub 2008 Aug 6.

Abstract

A handful of Henoch-Schönlein purpura (HSP) cases have been reported in HIV-infected adult patients. We report herein the case of an 11-year-old Thai girl with HIV infection, who developed severe abdominal pain and palpable purpura consistent with HSP, 3 months after planned antiretroviral treatment interruption (PTI). One month later she developed thrombocytopenia. It is possible that an HIV effect on vascular endothelium or PTI-associated immune activation contributed to HSP and thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Anti-HIV Agents* / administration & dosage
  • Child
  • Drug Administration Schedule*
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1
  • Humans
  • IgA Vasculitis / etiology*
  • Reverse Transcriptase Inhibitors* / administration & dosage
  • Thailand
  • Thrombocytopenia / etiology*

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors